CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Clinical Significance of Concordance or Discordance Between Fractional Flow Reserve and Coronary Flow Reserve for Coronary Physiological Indices, Microvascular Resistance, and Prognosis After Elective Percutaneous Coronary Intervention Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy JACC Guideline Comparison: JACC State-of-the-Art Review

Review Article2020 Jun 5;S0033-0620(20)30123-7.

JOURNAL:Prog Cardiovasc Dis. Article Link

Acute Myocardial Injury in Patients Hospitalized With COVID-19 Infection: A Review

C Bavishia, RO Bonow, DL Bhatt et al. Keywords: biomarkers; COVID-19; management; myocardial injury; prognosis

ABSTRACT